BSD Medical Corp. (BSDM) to Distribute Cancer Fighting Hyperthermia System in Italy and Europe
Source: http://Blog.QualityStocks.net/?p=10551Posted on Tuesday, June 10th, 2008 | In Current Market News, OTCBB Markets, Small & Micro Cap, Stocks to Watch
BSD Medical Corp. (Nasdaq: BSDM) is part of the global fight against cancer. The company develops systems for cancer therapies requiring precision-focused heat through microwave technologies. Today the company announced its European distributor was awarded a contract from Azienda Ospedaliera Institui Ospitalieri Di Verona (the Institute) to replace its existing hyperthermia system with BSD’s BSD-2000/3D system.
The BSD-2000/3D deep regional hyperthermia system is scheduled for delivery in August 2008, and will replace the Institute’s current system, which has been used since 1996. The BSD-2000/3D will be the first of its kind in Italy, and the 15th utilized in Europe.
“We are pleased to further expand our activities in the field of clinical hyperthermia, the single most potent radiation sensitizer available. We are looking forward to close working relationships with all of the ESHO [European Society for Hyperthermic Oncology] member institutes in advancing hyperthermia cancer treatment,†Dr. Sergio Maluta, head of the Radiation Oncology Department at the Institute stated in the press release.
The hyperthermia system uses 3-D steering to allow for a precisely focused energy to be administered into cancerous tumors, raising the tumor’s temperature to levels required for hyperthermia therapy to destroy the cancer cells with heat. The technology even allows for the treatment of tumors located deep in the body, increasing the effectiveness of radiation therapy.
The technology is integral to the Institute, which conducts more than 40,000 radiation treatments each year. As a member of ESHO, the Institute partakes in numerous major European clinical hyperthermia trials to treat several cancers, including advanced prostate cancer, as well as rectal, cervical, bladder, breast, head and neck cancer.
Let us hear your thoughts below:
Last 5 posts by QualityStocks
- Omnicity Corp. (OMCY.OB) Announces Addition of New Board Member - November 20th, 2009
- Muscle Flex, Inc. (MFLI.PK) Announces Release Time for the BUDDY Tablet Caddy Two-Minute Commercial and Landing Page - November 20th, 2009
- Artfest International, Inc. (ARTS.OB) Announces Revenue Profit Jumps - November 20th, 2009
- Omnicity Corp.’s (OMCY.OB) Recently-Issued Corporate Update - November 20th, 2009
- Soligenix Inc. (SNGX.OB) Taking Steps to Meet Challenges of Vaccine Technology and Biological Warfare - November 20th, 2009
3d System, Bladder Cancer, Breast Cancer, Bsd Medical Corp, Cancer Cells, Cancer Therapies, Cancer Treatment, Cancerous Tumors, Current Market News, European Distributor, Global Fight, Head And Neck Cancer, Member Institutes, Microwave Technologies, OTCBB Markets, Prostate Cancer, Radiation Oncology Department, Radiation Sensitizer, Radiation Therapy, Radiation Treatments, Regional Hyperthermia, Small & Micro Cap, Stocks to Watch, Working Relationships
![]() About QualityStocks (http://QualityStocks.net)
Our name, QualityStocks, emphasizes our commitment to connect subscribers with companies that have huge potential to succeed in the short and long-term future. We believe strong management and vision for the future are crucial for any company to be successful. Timing is everything and we help investors succeed by providing an objective, broad-based view of the SmallCap markets on a daily basis. Please see disclaimer on QualityStocks website: http://disclaimer.qualitystocks.net |



